{
    "componentChunkName": "component---src-templates-blog-post-js",
    "path": "/posts/73d1409a98f411ec8950d5f285f34a2b/",
    "result": {"data":{"allMysqlLists":{"edges":[{"node":{"title":"Covid-19 vaccine Novavax approved for use in New Zealand","status":1,"alt":"","src":"https://www.rnz.co.nz/assets/news_crops/139160/eight_col_000_32472GV.jpg?1646089481","source":"rnz","menu":"national","local_src":"","load_img":"","img_url":"https://www.rnz.co.nz/assets/news_crops/139160/three_col_000_32472GV.jpg?1646089481","href":"https://www.rnz.co.nz/news/national/462509/covid-19-vaccine-novavax-approved-for-use-in-new-zealand","description":"The Novavax Covid-19 vaccine has been approved in New Zealand for those aged 18 and over.","country":"nz","create_time":"2022-02-28T16:14:44.000Z","content":"[\"The Novavax Covid-19 vaccine has been approved in New Zealand for those aged 18 and over.\", \"<img src=\\\"https://www.rnz.co.nz/assets/news_crops/139160/eight_col_000_32472GV.jpg?1646089481\\\" alt=\\\"Vials with the Nuvaxovid vaccine against the Covid-19 coronavirus are seen at the CIZ Tegel vaccination center in Berlin.\\\" class=\\\"abcImg\\\"></img>\", \"<div class=\\\"imgText\\\">\\nVials with the Nuvaxovid vaccine against the Covid-19 coronavirus are seen at the CIZ Tegel vaccination center in Berlin. \\nPhoto: AFP or licensors\\n</div>\", \"The first doses are expected to arrive this month.\", \"The Novavax vaccine Nuvaxovid is the fourth vaccine to be approved by Medsafe.\", \"Pfizer/BioNTech, AstraZeneca and Janssen are all approved for use in New Zealand.\", \"Nuvaxovid is a two-dose protein subunit vaccine.\"]","href_hash":"73d1409a98f411ec8950d5f285f34a2b"}}]}},"pageContext":{"slug":"73d1409a98f411ec8950d5f285f34a2b"}},
    "staticQueryHashes": ["3649515864","764694655"]}